Related references
Note: Only part of the references are listed.Serial Measurement of Cell-Cycle Arrest Biomarkers [TIMP-2] • [IGFBP7] and Risk for Progression to Death, Dialysis, or Severe Acute Kidney Injury in Patients with Septic Shock
Marco Fiorentino et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference A Consensus Statement
Marlies Ostermann et al.
JAMA NETWORK OPEN (2020)
Use of Cell Cycle Arrest Biomarkers in Conjunction With Classical Markers of Acute Kidney Injury
Michael Joannidis et al.
CRITICAL CARE MEDICINE (2019)
The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: A multicenter, prospective, observational study
O. G. Rewa et al.
JOURNAL OF CRITICAL CARE (2019)
Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study
Blaithin A. McMahon et al.
AMERICAN JOURNAL OF NEPHROLOGY (2019)
The effect of early renal replacement therapy guided by plasma neutrophil gelatinase associated lipocalin on outcome of acute kidney injury: A feasibility study
Nattachai Srisawat et al.
JOURNAL OF CRITICAL CARE (2018)
The prognostic importance of duration of AKI: a systematic review and meta-analysis
Swati Mehta et al.
BMC NEPHROLOGY (2018)
Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial)
Nuttha Lumlertgul et al.
CRITICAL CARE (2018)
Resistin and NGAL are associated with inflammatory response, endothelial activation and clinical outcomes in sepsis
Stephen P. J. Macdonald et al.
INFLAMMATION RESEARCH (2017)
Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial
Melanie Meersch et al.
INTENSIVE CARE MEDICINE (2017)
Diagnosis and outcomes of acute kidney injury using surrogate and imputation methods for missing preadmission creatinine values
Amelie Bernier-Jean et al.
BMC NEPHROLOGY (2017)
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity
Jay L. Koyner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Urinary Angiotensinogen Level Predicts AKI in Acute Decompensated Heart Failure: A Prospective, Two-Stage Study
Xiaobing Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury
Sharidan K. Parr et al.
KIDNEY INTERNATIONAL (2015)
The growth of acute kidney injury: a rising tide or just closer attention to detail?
Edward D. Siew et al.
KIDNEY INTERNATIONAL (2015)
Net Reclassification Indices for Evaluating Risk Prediction Instruments A Critical Review
Kathleen F. Kerr et al.
EPIDEMIOLOGY (2014)
Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery
John M. Arthur et al.
KIDNEY INTERNATIONAL (2014)
Urinary Angiotensinogen and Risk of Severe AKI
Joseph L. Alge et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Biomarkers Predict Progression of Acute Kidney Injury after Cardiac Surgery
Jay L. Koyner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Risk of Poor Outcomes with Novel and Traditional Biomarkers at Clinical AKI Diagnosis
Isaac E. Hall et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population
Dinna N. Cruz et al.
INTENSIVE CARE MEDICINE (2010)
Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness
Sean M. Bagshaw et al.
INTENSIVE CARE MEDICINE (2010)
Peer review of statistics in medical research: the other problem
P Bacchetti
BRITISH MEDICAL JOURNAL (2002)